First Choice Neurology Research Center 32 Clinical Trials
First Choice Neurology Research Center 32 offers clinical trials for Migraines, Alzheimer’s disease, Hypotension, Multiple Sclerosis, Parkinson’s disease, Epilepsy, and other neurological disorders.
Migraine Clinical Studies
A phase 2/3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral Zavegepant in migraine prevention.
A phase 4 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety or Rimegepant in episodic migraine prevention with multiple dosing regimens.
Chronic Migraine: A phase 3 multicenter 24-week open-label study to evaluate the safety, tolerability, and efficacy of Atogepant when added to OnabotulinumtoxinA (BOTOX) for the prevention of treatment of chronic migraine.
Episodic Migraine: Phase 3 study of BOTOX (Botulinum Toxin Type A) for the prevention of migraine in subjects with episodic migraine.
Alzheimer's Disease Clinical Studies
A phase 3, randomized, double-blind, placebo-controlled, parallel-group, 52-week study evaluating the safety and efficacy of Simufilam 100mg tablets in subjects with mild-to-moderate Alzheimer’s Disease.
Eli Lilly I5T-MC-AACM
A study of donanemab versus placebo in participants at risk for cognitive and functional decline for Alzheimer’s Disease.
Multiple Sclerosis Clinical Studies
Celgene RPC-1063-MS-001- A multicenter, longitudinal, open-label, single-arm study describing cognitive processing speed changes in relapsing multiple sclerosis subjects treated with Ozanimod (RPC-1063).
Contact First Choice Neurology Research Center 32
Neurology Office of South Florida, LLC
9970 Central Park Blvd., Suite 207
Boca Raton, FL 33428
Phone: (561) 482-1027
Fax: (561) 482-1028
Cody Paauwe, CRC
(561) 482-1027 ext. 9